Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction

article OA: closed CC0 ⤵ 29 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

This study investigated the short-term outcomes of MRI-guided focused ultrasound surgery for adenomyosis, reporting on symptomatic relief and pain reduction experienced by patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The objective of this study was to evaluate the degree of symptomatic relief obtained after treatment with magnetic resonance-guided focused ultrasound surgery in patients with adenomyosis. Quality of life and pain assessment questionnaires from 35 women, collected on the day of treatment and up to 6 months after treatment, indicated that the treatment was safe and there was a significant reduction in symptoms.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_painadenomyosis

MeSH descriptors

Endometriosis Magnetic Resonance Imaging Pelvic Pain Ultrasonography, Interventional Ablation Techniques Adult Endometriosis Endometriosis Endometriosis Female Follow-Up Studies Humans Middle Aged Pelvic Pain Pelvic Pain Pelvic Pain Surveys and Questionnaires Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Cited by (30)

Source provenance

europepmc
last seen: 2026-08-15T06:15:18.721777+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:00.782903+00:00
unpaywall
last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0 · commercial use OK